Vanguard Group’s Lifecore Biomedical LFCR Stock Holding History

Vanguard Group’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$13.7M	Buy	1,673,666 +50,897	+3%	+$377K	﹤0.01%	2801
2025 Q3	$11.9M	Buy	1,622,769 +12,851	+0.8%	+$97.2K	﹤0.01%	2883
2025 Q2	$13.1M	Buy	1,609,918 +63,301	+4%	+$427K	﹤0.01%	2758
2025 Q1	$10.9M	Buy	1,546,617 +15,964	+1%	+$99.2K	﹤0.01%	2800
2024 Q4	$11.4M	Buy	1,530,653 +215,437	+16%	+$1.38M	﹤0.01%	2886
2024 Q3	$6.48M	Buy	1,315,216 +25,208	+2%	+$132K	﹤0.01%	3163
2024 Q2	$6.62M	Buy	1,290,008 +105,152	+9%	+$623K	﹤0.01%	3124
2024 Q1	$6.29M	Sell	1,184,856 -165,711	-12%	-$1.19M	﹤0.01%	3201
2023 Q4	$8.36M	Hold	1,350,567	–	–	﹤0.01%	3054
2023 Q3	$10.2M	Hold	1,350,567	–	–	﹤0.01%	2864
2023 Q2	$13.1M	Sell	1,350,567 -114,117	-8%	-$697K	﹤0.01%	2798
2023 Q1	$5.53M	Buy	1,464,684 +190,815	+15%	+$1.06M	﹤0.01%	3255
2022 Q4	$8.25M	Buy	1,273,869 +5,770	+0.5%	+$47.6K	﹤0.01%	3040
2022 Q3	$11.3M	Sell	1,268,099 -3,488	-0.3%	-$35.5K	﹤0.01%	2903
2022 Q2	$12.7M	Sell	1,271,587 -58,313	-4%	-$577K	﹤0.01%	2860
2022 Q1	$15.4M	Buy	1,329,900 +72,064	+6%	+$802K	﹤0.01%	2921
2021 Q4	$14M	Sell	1,257,836 -182,219	-13%	-$1.77M	﹤0.01%	3042
2021 Q3	$13.3M	Buy	1,440,055 +42,060	+3%	+$458K	﹤0.01%	3086
2021 Q2	$15.7M	Sell	1,397,995 -281,169	-17%	-$3.24M	﹤0.01%	2959
2021 Q1	$17.8M	Buy	1,679,164 +7,323	+0.4%	+$82.3K	﹤0.01%	2846
2020 Q4	$18.1M	Sell	1,671,841 -406,673	-20%	-$4.2M	﹤0.01%	2687
2020 Q3	$20.2M	Buy	2,078,514 +395,645	+24%	+$3.77M	﹤0.01%	2455
2020 Q2	$13.4M	Sell	1,682,869 -188,002	-10%	-$1.94M	﹤0.01%	2623
2020 Q1	$16.3M	Buy	1,870,871 +251,769	+16%	+$2.62M	﹤0.01%	2383
2019 Q4	$18.3M	Sell	1,619,102 -134,045	-8%	-$1.43M	﹤0.01%	2578
2019 Q3	$19.1M	Sell	1,753,147 -59,336	-3%	-$646K	﹤0.01%	2516
2019 Q2	$17M	Buy	1,812,483 +218,927	+14%	+$2.21M	﹤0.01%	2592
2019 Q1	$19.6M	Sell	1,593,556 -10,365	-0.6%	-$127K	﹤0.01%	2515
2018 Q4	$19M	Buy	1,603,921 +68,404	+4%	+$939K	﹤0.01%	2466
2018 Q3	$22.1M	Buy	1,535,517 +63,494	+4%	+$878K	﹤0.01%	2535
2018 Q2	$21.9M	Buy	1,472,023 +64,740	+5%	+$900K	﹤0.01%	2526
2018 Q1	$18.4M	Buy	1,407,283 +51,019	+4%	+$670K	﹤0.01%	2535
2017 Q4	$17.1M	Buy	1,356,264 +30,159	+2%	+$381K	﹤0.01%	2554
2017 Q3	$17.2M	Buy	1,326,105 +32,539	+3%	+$429K	﹤0.01%	2553
2017 Q2	$19.2M	Buy	1,293,566 +38,572	+3%	+$537K	﹤0.01%	2474
2017 Q1	$15.1M	Buy	1,254,994 +49,191	+4%	+$623K	﹤0.01%	2570
2016 Q4	$16.6M	Buy	1,205,803 +30,265	+3%	+$419K	﹤0.01%	2500
2016 Q3	$15.8M	Buy	1,175,538 +4,703	+0.4%	+$57K	﹤0.01%	2473
2016 Q2	$12.6M	Buy	1,170,835 +68,400	+6%	+$755K	﹤0.01%	2538
2016 Q1	$11.6M	Buy	1,102,435 +108,412	+11%	+$1.19M	﹤0.01%	2534
2015 Q4	$11.8M	Sell	994,023 -22,420	-2%	-$275K	﹤0.01%	2552
2015 Q3	$11.9M	Buy	1,016,443 +193,548	+24%	+$2.56M	﹤0.01%	2515
2015 Q2	$11.9M	Buy	822,895 +9,894	+1%	+$143K	﹤0.01%	2580
2015 Q1	$11.3M	Sell	813,001 -22,547	-3%	-$312K	﹤0.01%	2587
2014 Q4	$11.5M	Buy	835,548 +3,163	+0.4%	+$40.9K	﹤0.01%	2480
2014 Q3	$10.2M	Buy	832,385 +41,356	+5%	+$516K	﹤0.01%	2487
2014 Q2	$9.88M	Buy	791,029 +38,048	+5%	+$448K	﹤0.01%	2509
2014 Q1	$8.4M	Buy	752,981 +45,497	+6%	+$499K	﹤0.01%	2568
2013 Q4	$8.57M	Buy	707,484 +34,474	+5%	+$412K	﹤0.01%	2537
2013 Q3	$8.21M	Buy	673,010 +6,400	+1%	+$89.3K	﹤0.01%	2486
2013 Q2	$8.81M	Buy	+666,610	New	+$9.22M	﹤0.01%	2387

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return